Delivery Order SPE2DR25D9114-SPE2DR26FMEE6
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,458.51 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules (30-count). This firm fixed-price delivery order, issued on November 4, 2025, with an ultimate completion date of November 26, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The...
- The Defense Logistics Agency awarded a $10,588.89 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules (30-count units). The delivery order, issued on November 12, 2025, with completion scheduled by December 4, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award is...
- The Defense Logistics Agency awarded a delivery order valued at $3,529.63 to DMS Pharmaceutical Group Inc. for 30-count bottles of Nuplazid 34 mg capsules, with a completion date of January 15, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a firm fixed-price purchase issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,588.89 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules (30-count packaging). This firm fixed-price delivery order, issued on December 17, 2025, with an ultimate completion date of January 9, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted...
- The Defense Logistics Agency awarded a $10,588.89 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules (30-count units). The delivery order, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, carries no set-aside designation, indicating the award was made through open competition. This delivery order is issued under DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $10,375.53 by the Defense Logistics Agency on July 18, 2025, for the supply of Nuplazid 34 mg capsules (30-count units). This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, carries no set-aside designation and will be performed at the contractor's Park Ridge, Illinois location. The award represents a...
- The Defense Logistics Agency awarded a delivery order valued at $10,588.89 to DMS Pharmaceutical Group Inc. for 30 capsules of Nuplazid 34 mg on November 28, 2025. This firm fixed-price delivery order, issued without set-aside designation, will be performed in Park Ridge, Illinois, with an ultimate completion date of December 19, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Illinois, serves as the sole awardee and has been...
- The Defense Logistics Agency awarded a $23,542.92 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Nuplazid 34 mg capsules (30-count units) with an ultimate completion date of January 28, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. This delivery order was...
- The Defense Logistics Agency awarded a delivery order valued at $10,588.89 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules (30-count packages). The award, issued on October 28, 2025, with an ultimate completion date of November 19, 2025, utilizes firm fixed-price pricing and does not include a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,925.34 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 10 mg tablets in a 30-count package. The delivery order, issued without a set-aside designation, is scheduled for completion by January 21, 2026, and represents a routine pharmaceutical procurement to support Department of Defense medical supply requirements....
- SPE2DR25D9114Indefinite Delivery Contract
- SPE2DR25D9114-SPE2DR26FMEE6Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $47,085.84 by the Defense Logistics Agency for the supply of Nuplazid 34 mg capsules (30-count units). The delivery order, issued on January 8, 2026, with an ultimate completion date of January 30, 2026, carries no set-aside designation, indicating the company competed in open procurement. This award is issued under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy established to supply pharmaceutical products to Department of Defense healthcare facilities worldwide. The PPV-G GEN V contract, awarded to DMS Pharmaceutical Group on November 13, 2025, with a $499,999,999 ceiling and completion date of December 31, 2036, positions the company as a regional prime vendor contractor serving military healthcare operations globally. Through this vehicle, DLA issues firm fixed-price delivery orders for comprehensive pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. DMS Pharmaceutical Group's demonstrated performance across numerous delivery orders and its established presence in the federal pharmaceutical supply chain since 2001 underscore its capability to fulfill the specialized and diverse pharmaceutical requirements of the military medical system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $47.1k | 1/7/26 |